Learning Objectives:

1. Review existing understanding of the genomics and immune environment in DLBCL

2. Discuss a computational approach in examining the immune environment in DLBCL

3. Discuss ongoing work using transcriptomics to identify markers of early relapse in DLBCL after CAR-T cell therapy.

Session date: 
Monday, October 18, 2021 - 12:00pm to 1:00pm
Virtually Virtually
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Jovian Yu, MD